SEARCH

SEARCH BY CITATION

In the December 2013 issue of Hepatology, in the article titled “Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor” (volume 58, pages 2001-2011; doi: 10.1002/hep.26585), by Audrey Clapéron, Martine Mergey, Lynda Aoudjehane, Thanh Huong Nguyen Ho-Bouldoires, Dominique Wendum, Aurélie Prignon, Fatiha Merabtene, Delphine Firrincieli, Christèle Desbois-Mouthon, Olivier Scatton, Filomena Conti, Chantal Housset, and Laura Fouassier, images corresponding to the cell preparation CM3 in Fig. 5C were inadvertently substituted for those corresponding to CM1 in the two lower panels (Aba-EGFR and gefitinib); and in Fig. 6B, images corresponding to the Control (control medium) and to HB-EGF + Gefitinib were substituted for a panel belonging to Fig. 6A. The corrected versions of Figure 5C and 6B are provided below.

Thumbnail image of
Thumbnail image of

The publisher regrets the error.